OQROGet OQRO Pro
Politician trade (Senate)

ResMed| (RMD)Sen. Alan Armstrong disclosed a purchase $1K–$15K

Sen. Alan Armstrong disclosed a purchase of ResMed| in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
116 days
Disclosure lag
Traded
Mar 27, 2026
Disclosed
Jul 21, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jan 29, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  2. Feb 2, 2026InsiderCFO sold ~$257K of RMD shares in the open market
  3. Feb 4, 2026Insider · 2 peopleInsiders: 2 sales (~$516K)
  4. Feb 9, 2026InsiderCEO sold ~$1.37M of RMD shares in the open market
  5. Feb 23, 2026FDAFDA device clearance: Mariana Minerva; Mariana Nimbus
  6. Mar 2, 2026InsiderCFO sold ~$254K of RMD shares in the open market
  7. Mar 4, 2026InsiderDirector sold ~$520K of RMD shares in the open market
  8. Mar 9, 2026InsiderCEO sold ~$1.25M of RMD shares in the open market
  9. Mar 27, 2026 · this disclosureCongressDisclosed purchase of RMD — reported range $1,001 - $15,000

What came next

  1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  2. Apr 1, 2026Insider · 2 peopleInsiders: 2 sales (~$674K)
  3. Apr 7, 2026InsiderCEO sold ~$1.13M of RMD shares in the open market
  4. Apr 8, 2026FDAFDA device clearance: myAir
  5. Apr 24, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On April 30, 2026, ResMed Inc. (the “Company”) announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.”
  6. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 8.2%
  7. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 5.4%
  8. Apr 30, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  9. May 7, 2026InsiderCEO sold ~$1.04M of RMD shares in the open market
  10. May 27, 2026FDAFDA device clearance: ResScan Essentials
  11. Jun 4, 2026FDAFDA device clearance: Orion
  12. Jun 8, 2026InsiderCEO sold ~$968K of RMD shares in the open market
  13. Jun 25, 2026FDARecall: Resmed Astral 100/150 Resmed Astral 100/50 is a ventilator system that provides continuous or intermittent ventilatory support for patients weighing more than…
  14. Jun 30, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  15. Jul 7, 2026InsiderCEO sold ~$1.09M of RMD shares in the open market
View the official recordSenate eFD periodic transaction report

How to read Senate eFD periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for ResMed|

For ResMed|, OQRO holds 8 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 19 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its RMD page.

Other recent filings by Sen. Alan Armstrong

The full history of Sen. Alan Armstrong is on the profile page.

How this filing works

Other disclosures at ResMed|

Everything OQRO holds on this company is on its RMD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data